Antipsychotics in individuals with intellectual disability/Authors' reply

We applaud Peter Tyrer and colleagues for attempting critical assessment of the effectiveness of antipsychotic drugs in the treatment of aggressive behaviour in people with intellectual disability (Jan 5, p 57).1 Although a welcome catalyst for debate, their finding that placebo was equally effectiv...

Full description

Saved in:
Bibliographic Details
Published inThe Lancet (British edition) Vol. 371; no. 9623; p. 1501
Main Authors Trollor, Julian N, Somerville, Ernest R, Somerville, Helen M, Turk, Jeremy, Bramble, David, Levitas, Andrew, Gainotti, Sabina, Galeotti, Francesca, Izzicupo, Fabio, Petrini, Carlo, Raschetti, Roberto, Tyrer, Peter, Oliver-Africano, Patricia, Murphy, Declan, Crawford, Mike, Harley, Dave
Format Journal Article
LanguageEnglish
Published London Elsevier Limited 03.05.2008
Subjects
Advance directives
Aggressive behavior
Alzheimer's disease
Antipsychotics
Clinical medicine
Decision making
Disability
Drugs
Hospitals
Informed consent
Intellectual disabilities
Learning disabilities
Mental institutions
Patients
Psychotropic drugs
Online AccessGet full text

Cover

More Information
Summary:We applaud Peter Tyrer and colleagues for attempting critical assessment of the effectiveness of antipsychotic drugs in the treatment of aggressive behaviour in people with intellectual disability (Jan 5, p 57).1 Although a welcome catalyst for debate, their finding that placebo was equally effective has unfortunately already received simplistic media attention23 and will inevitably cause anxiety for many carers and professionals.
ISSN:0140-6736
1474-547X